| # | Drug | Count |
|---|---|---|
| 0 | DUPILUMAB | 12 |
| 1 | BENRALIZUMAB | 11 |
| 2 | MEPOLIZUMAB | 11 |
| 3 | OMALIZUMAB | 5 |
| 4 | MONTELUKAST | 4 |
| 5 | FLUTICASONE FUROATE, UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE | 3 |
| 6 | PREDNISOLONE | 3 |
| 7 | PREDNISOLONE ORAL | 3 |
| 8 | PREDNISOLONE ORAL SOLUTION | 3 |
| 9 | AZATHIOPRINE | 2 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ARNICA MONTANA, HYPERICUM PERFORATUM, LEDUM PALUSTRE, MORBILLINUM, NATRUM MURIATICUM, SILICEA, SULPHUR IODATUM, THUJA OCCIDENTALIS, URTICA URENS | 1 | 0.0047 |
| 1 | HYALURONATE SODIUM | 1 | 0.0007 |
| 2 | BENRALIZUMAB | 11 | 0.0005 |
| 3 | AMOXICILLIN AND CLAVULANATE POTASSIUM | 1 | 0.0002 |
| 4 | MEPOLIZUMAB | 11 | 0.0002 |
| 5 | VONOPRAZAN FUMARATE | 1 | 0.0001 |
| 6 | DESLORATADINE | 1 | 0.0001 |
| 7 | THEOPHYLLINE ANHYDROUS | 1 | 0.0001 |
| 8 | FLUTICASONE FUROATE, UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE | 3 | 0.0001 |
| 9 | OMALIZUMAB | 5 | 0.0001 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-5 Antagonist [EPC] | 11 | 0.0160 |
| 1 | Interleukin-5 Receptor alpha-directed Cytolytic Antibody [EPC] | 11 | 0.0005 |
| 2 | Anti-IgE [EPC] | 5 | 0.0001 |
| 3 | Leukotriene Receptor Antagonist [EPC] | 1 | 0.0000 |
| 4 | Interleukin-4 Receptor alpha Antagonist [EPC] | 12 | 0.0000 |
| 5 | Purine Antimetabolite [EPC] | 2 | 0.0000 |
| 6 | Macrolide Antimicrobial [EPC] | 1 | 0.0000 |
| 7 | Methylxanthine [EPC] | 1 | 0.0000 |
| 8 | Histamine-1 Receptor Antagonist [EPC] | 1 | 0.0000 |
| 9 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 1 | 0.0000 |